USPTO 2015–2025 USPTO PatentsView US Corporation

Eutropics Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.4

Avg claims per patent

-17%

5-year filing velocity

The verdict

Eutropics holds 11 US patents across 10 technology areas, rank #24,302 of 50,000 tracked assignees.

#24,302
of 50,000 US assignees by volume: Top 72%
by Innovation Score (28.5/100): 12.4
avg claims per patent: -17%
filing velocity, last 5 yrs

Portfolio overview

Eutropics Pharmaceuticals, Inc. has been granted 11 US utility patents between 2015 and 2023, placing Eutropics Pharmaceuticals, Inc. at rank #24,302 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.4 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Eutropics Pharmaceuticals, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Eutropics sits between Erwin Junker Maschinenfabrik Gmbh (11 patents, rank #24,298) and Exinda Networks PTY, Ltd. (11 patents, rank #24,306) - the closest US assignees by grant volume. The composite Innovation Score of 28.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Eutropics Pharmaceuticals, Inc.'s 12.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Eutropics Pharmaceuticals, Inc. against peers pursuing similar technology classes.

Erwin Junker Masc…

11
Esdec B V

11
Eseye

11
Estetra SPRL

11
Everpro

11
Everbridge

11
Evolv

11
Exinda Networks P…

11
Eutropics Pharmac… ◀

11

What this shows Eutropics holds 11 patents at rank #24,302, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Eutropics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

29 Top 72% higher than 28% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Eutropics Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	3	27.3%
2019	1	9.1%
2020	4	36.4%
2023	1	9.1%

Which technologies does Eutropics Pharmaceuticals, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 6

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5

C07D - HETEROCYCLIC COMPOUNDS 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 2

C07K - PEPTIDES 2

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#24,302

Across all tracked assignees

Innovation Score

28.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Eutropics Pharmaceuticals, Inc. hold?

Eutropics Pharmaceuticals, Inc. holds 11 US granted patents filed between 2015 and 2023, spanning 10 technology areas.

What is Eutropics Pharmaceuticals, Inc.'s Innovation Score?

Eutropics Pharmaceuticals, Inc. has an Innovation Score of 28.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Eutropics Pharmaceuticals, Inc. focus on?

Eutropics Pharmaceuticals, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 8 patents. The company has filed patents in 10 CPC subclasses total.

Is Eutropics Pharmaceuticals, Inc.'s patent filing rate increasing or decreasing?

Eutropics Pharmaceuticals, Inc.'s recent filing velocity is -17% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Eutropics Pharmaceuticals, Inc.'s patents?

Eutropics Pharmaceuticals, Inc.'s patents average 12.4 claims each. This falls within the standard range, providing solid legal coverage.

How is the Eutropics Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Eutropics's 11 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Eutropics ranks #24,302 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.